Interventional Oncology Devices | Medtech 360 | Market Analysis | US | 2019
The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in this market will be hindered to some extent by mixed clinical data, which has somewhat deterred adoption of interventional oncology devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the US across a 10-year period.